Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study
Author(s):
Maerevoet, M.; Vermaat, J.; Canales, M.A.; Casasnovas, R.O.; Neste, E. van den; Goy, A.; Hill, B.T.; Thieblemont, C.; Cruz, M.D. de la; Cavallo, F.; Follows, G.; Choquet, S.; Gurion, R.; Bouabdallah, R.; Jaeger, U.; Nagy, A.; Kuruvilla, J.; Warzocha, K.; Kalakonda, N.; Caimi, P.; Bakhshi, S.; Ku, M.; Hamad, N.; Veelken, H.; Matczak, E.; Ma, X.W.; Saint-Martin, J.R.; Shah, J.J.; Kauffman, M.G.; Shacham, S.; Zijlstra, J.M.
